Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U4 small nuclear 17, pseudogene (RNU4-17P) is a pseudogene located at cytogenetic region 18q21.32 on chromosome 18 and is classified as a small nuclear RNA pseudogene. As a pseudogene, it does not encode a functional protein or active non-coding RNA product and, therefore, does not participate in known cellular or biological processes. It is not recognized as a therapeutic target, biomarker, or disease gene, and there are no known drugs, biological functions, or disease associations linked to it. The RNU4-17P sequence shows homology with functional U4 small nuclear RNA genes, which participate in the spliceosome complex, but RNU4-17P itself is not functional due to its classification as a pseudogene. Pseudogenes such as this are generally considered non-functional genomic elements that have lost their gene expression capability and/or protein-coding potential, often due to mutations or sequence alterations. Functional U4 small nuclear RNAs are critical in the splicing of pre-mRNA as part of the major spliceosome, but this does not apply to RNU4-17P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 17, pseudogene (RNU4-17P).